42 C.F.R. § 425.610
(a)
General rule. For each performance year, CMS determines whether the estimated average per capita Medicare expenditures under the ACO for Medicare fee-for-service beneficiaries for Parts A and B services are above or below the updated benchmark determined under §
425.601,
425.602,
425.603, or
425.652. In order to qualify for a shared savings payment under the ENHANCED track, or to be responsible for sharing losses with CMS, an ACO's average per capita Medicare expenditures under the ACO for Medicare fee-for-service beneficiaries for Parts A and B services for the performance year must be below or above the updated benchmark, respectively, by at least the minimum savings or loss rate under
paragraph (b) of this section.
(1)
Risk adjustment for ACOs in agreement periods beginning on or before January 1, 2019. CMS does the following to adjust the benchmark each performance year:
(i)
Newly assigned beneficiaries. CMS uses an ACO's prospective HCC risk score to adjust the benchmark for changes in severity and case mix in this population.
(ii)
Continuously assigned beneficiaries.
(A)
CMS uses demographic factors to adjust the benchmark for changes in the continuously assigned beneficiary population.
(B)
If the prospective HCC risk score is lower in the performance year for this population, CMS adjusts the benchmark for changes in severity and case mix for this population using this lower prospective HCC risk score.
(2)
Risk adjustment for ACOs in agreement periods beginning on July 1, 2019, and in subsequent years. CMS uses an ACO's prospective HCC risk score to adjust the benchmark for changes in severity and case mix in the assigned beneficiary population between BY3 and the performance year.
(i)
For agreement periods beginning before January 1, 2024—
(A)
Positive adjustments in prospective HCC risk scores are subject to a cap of 3 percent.
(B)
This cap is the maximum increase in risk scores for each agreement period, such that any positive adjustment between BY3 and any performance year in the agreement period cannot be larger than 3 percent.
(ii)
For agreement periods beginning on January 1, 2024, and in subsequent years—
(A)
Positive adjustments in prospective HCC risk scores are subject to a cap equal to the ACO's aggregate growth in demographic risk scores between BY3 and the performance year (positive or negative) plus 3 percentage points.
(B)
The cap described in
paragraph (a)(2)(ii)(A) of this section will apply to prospective HCC risk score growth for a population described in
paragraph (a)(3) of this section only if the ACO's aggregate growth in prospective HCC risk scores between BY3 and the performance year across all of the populations described in
paragraph (a)(3) of this section exceeds this cap. If the cap described in
paragraph (a)(2)(ii)(A) of this section is determined to apply, the value of the cap is the maximum increase in risk scores for the applicable performance year, such that any positive adjustment between BY3 and the performance year cannot be larger than the value of the cap for any of the populations described in
paragraph (a)(3) of this section.
(C)
The aggregate growth in demographic risk scores for purposes of
paragraph (a)(2)(ii)(A) of this section and the aggregate growth in prospective HCC risk scores for purposes of
paragraph (a)(2)(ii)(B) of this section is calculated by taking a weighted average of the growth in demographic risk scores or prospective HCC risk scores, as applicable, across the populations described in
paragraph (a)(3) of this section. When calculating the weighted average growth in demographic risk scores or prospective HCC risk scores, as applicable, the weight applied to the growth in risk scores (expressed as a ratio of the ACO's performance year risk score to the ACO's BY3 risk score) for each Medicare enrollment type is equal to the product of the ACO's historical benchmark expenditures, adjusted in accordance with
§ 425.652(a)(8), for that enrollment type and the ACO's performance year assigned beneficiary person years for that enrollment type.
(4)
(i)
For performance years before 2017 to minimize variation from catastrophically large claims, CMS truncates an assigned beneficiary's total annual Parts A and B fee-for-service per capita expenditures at the 99th percentile of national Medicare fee-for-service expenditures as determined for each performance year.
(ii)
For the 2017 performance year and subsequent performance years, to minimize variation from catastrophically large claims, CMS truncates an assigned beneficiary's total annual Parts A and B fee-for-service per capita expenditures at the 99th percentile of national Medicare fee-for-service expenditures as determined for the applicable performance year for assignable beneficiaries identified for the 12-month calendar year corresponding to the performance year.
(5)
CMS uses a 3-month claims run out with a completion factor to calculate an ACO's per capita expenditures for each performance year.
(6)
Calculations of the ACO's expenditures will include the payment amounts included in Part A and B fee-for-service claims.
(i)
These calculations will exclude indirect medical education (IME) and disproportionate share hospital (DSH) payments, and the supplemental payment for IHS/Tribal hospitals and Puerto Rico hospitals.
(ii)
These calculations will take into consideration individually beneficiary identifiable payments made under a demonstration, pilot or time limited program.
(A)
For performance years beginning before 2018, these calculations will take into consideration all individually beneficiary identifiable payments, including interim payments, made under a demonstration, pilot or time limited program.
(B)
For performance year 2018 and subsequent performance years, these calculations will take into consideration individually beneficiary identifiable final payments made under a demonstration, pilot or time limited program.
(7)
In order to qualify for a shared savings payment, the ACO's average per capita Medicare expenditures for the performance year must be below the applicable updated benchmark by at least the minimum savings rate established for the ACO under
paragraph (b) of this section.
(h)
Notification of savings and losses.
(1)
CMS notifies an ACO in writing regarding whether the ACO qualifies for a shared savings payment, and if so, the amount of the payment due.
(2)
CMS provides written notification to an ACO of the amount of shared losses, if any, that it must repay to the program.
(3)
If an ACO has shared losses, the ACO must make payment in full to CMS within 90 days of receipt of notification.
(i)
Extreme and uncontrollable circumstances. For performance year 2017 and subsequent performance years, the following adjustment is made in calculating the amount of shared losses, after the application of the shared loss rate in
paragraph (f) of this section and the loss recoupment limit in
paragraph (g) of this section.
(1)
CMS determines the percentage of the ACO's performance year assigned beneficiary population affected by an extreme and uncontrollable circumstance.
(2)
CMS reduces the amount of the ACO's shared losses by an amount determined by multiplying the shared losses by the percentage of the total months in the performance year affected by an extreme and uncontrollable circumstance, and the percentage of the ACO's assigned beneficiaries who reside in an area affected by an extreme and uncontrollable circumstance.
(i)
For an ACO that is liable for a pro-rated share of losses under §
425.221(b)(2)(ii) or
(b)(3)(i), the amount of shared losses determined for the performance year during which the termination becomes effective is adjusted according to this paragraph (i)(2).
(ii)
For performance year 2025 and subsequent performance years, for an ACO as defined at
§ 425.20 that is determined to be affected by an extreme and uncontrollable circumstance due to a cyberattack, including ransomware/malware, for any month of the performance year that is affected, CMS considers 100 percent of the ACO's assigned beneficiaries to reside in an affected area.
(3)
CMS applies determinations made under the Quality Payment Program with respect to all of the following (as applicable):
(i)
Whether an extreme and uncontrollable circumstance has occurred.
(iii)
The time period during which the ACO was affected by a cyberattack, including ransomware/malware.
(4)
CMS determines the time period during which an ACO is affected by a cyberattack, including ransomware/malware, as follows:
(i)
CMS uses the start and end date indicated on an ACO's application to the Quality Payment Program for an extreme and uncontrollable circumstance exception due to a cyberattack, including ransomware/malware, or the start date indicated on the application and an end date subsequently provided by the ACO in the form and manner as specified by CMS.
(ii)
Except as specified in paragraph (i)(4)(iii) of this section, if no end date is indicated on the ACO's application or otherwise provided to CMS in a form and manner specified by CMS, described in paragraph (i)(4)(i) of this section, CMS applies a 90-day duration for purposes of determining the time period during which the ACO was affected by the extreme and uncontrollable circumstance.
(iii)
If the start date indicated on the ACO's application described in paragraph (i)(4)(i) of this section is less than 90 days before the end of the performance year and no end date is indicated on the ACO's application or otherwise provided to CMS in the form and manner specified by CMS, described in paragraph (i)(4)(i) of this section, CMS applies an end date of December 31st of the performance year for purposes of determining the time period during which the ACO was affected by the extreme and uncontrollable circumstance.
(5)
CMS has sole discretion to determine the time period during which an extreme and uncontrollable circumstance occurred and the percentage of the ACO's assigned beneficiaries residing in the affected areas.
Notes, amendments, and revision history
Amendments
[80 FR 32842, June 9, 2015, as amended at 81 FR 38017, June 10, 2016; 82 FR 53370, Nov. 15, 2017; 82 FR 60918, Dec. 26, 2017; 83 FR 60096, Nov. 23, 2018; 83 FR 68079, Dec. 31, 2018; 85 FR 85044, Dec. 28, 2020; 87 FR 70240, Nov. 18, 2022; 89 FR 98571, Dec. 9, 2024; 90 FR 50019, Nov. 5, 2025]
Authority
Authority: 42 U.S.C. 1302, 1306, 1395hh, and 1395jjj.
Source
Source: 76 FR 67973, Nov. 2, 2011, unless otherwise noted.
Amendments
[80 FR 32842, June 9, 2015, as amended at 81 FR 38017, June 10, 2016; 82 FR 53370, Nov. 15, 2017; 82 FR 60918, Dec. 26, 2017; 83 FR 60096, Nov. 23, 2018; 83 FR 68079, Dec. 31, 2018; 85 FR 85044, Dec. 28, 2020; 87 FR 70240, Nov. 18, 2022; 89 FR 98571, Dec. 9, 2024; 90 FR 50019, Nov. 5, 2025]